Text messages could help latino diabetes patients stick to meds

NCT ID NCT06000813

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a mobile health tool called REACH-Español, which sends interactive text messages to help Latino adults with type 2 diabetes remember and take their medications. The trial included 70 participants who were at least 18 years old, identified as Latino or Hispanic, and had trouble sticking to their diabetes drugs. The goal was to see if the tool was easy to use and acceptable, and whether it could improve medication adherence and blood sugar control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
REACH-Español (interactive text message-based tool)
What this could lead to
If successful, this could provide a scalable, low-cost way to help Latino adults with type 2 diabetes better manage their medication and blood sugar levels.
What could go wrong
This was a small, early feasibility study with only 70 participants, so results may not apply to all Latino adults. The tool focuses on adherence, not a cure or major disease reversal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MEDICATION ADHERENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Medication Adherence type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hospital Diabetes Research Center

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.